PubMed · 1994 · 76 citations · 0 references
MedicinePharmacologyPsychiatryNeuropharmacologyPsychopharmacologyPsychotherapyAntidepressant TherapyAntipsychotic PharmacotherapyAnxiolytic TherapyBehavior TherapyObsessive-compulsive DisordersStimulant TherapyClinical ExhibitionismCompulsive DisordersImpulse ControlObsessive-compulsive Disorder TreatmentParaphilic DisordersPharmacology Of Serotonergic AgentsSelective Serotonin Reuptake Inhibitor TreatmentSelective Serotonin Reuptake Inhibitor Use
BACKGROUND: Paraphilias are psychosexual disorders that are usually conceptualized as deviant in nature. Yet in some cases, paraphilia can be conceptualized as an obsessive compulsive disorder. METHOD: We describe an exhibitionist treated under partial single-blind conditions (patient was blind to placebo but was aware he was receiving desipramine and fluvoxamine) with the serotonin selective reuptake inhibitor fluvoxamine, followed by desipramine and a placebo that looked like fluvoxamine, in an ABACA design. He was serially assessed with the Yale-Brown Obsessive Compulsive Scale. RESULTS: Fluvoxamine eliminated the undesired impulse and behavior without affecting sexual desire. Desipramine and single-blind fluvoxamine-placebo treatment were both associated with relapses. CONCLUSION: A subset of paraphiliacs may be suffering from obsessive-compulsive-related disorders and may benefit from serotonergic agents.